As of 2025-12-14, the Relative Valuation of Pfizer Inc (PFE) is 33.07 USD. This relative valuation is based on P/E multiples. With the latest stock price at 25.85 USD, the upside of Pfizer Inc based on Relative Valuation is 27.9%.
The range of the Relative Valuation is 24.80 - 48.65 USD.
| Range | Selected | |
| Trailing P/E multiples | 18.9x - 28.1x | 23.3x |
| Forward P/E multiples | 18.8x - 20.1x | 19.6x |
| Fair Price | 24.80 - 48.65 | 33.07 |
| Upside | -4.1% - 88.2% | 27.9% |
| Date | P/E |
| 2025-12-12 | 14.95 |
| 2025-12-11 | 14.92 |
| 2025-12-10 | 14.91 |
| 2025-12-09 | 14.65 |
| 2025-12-08 | 14.91 |
| 2025-12-05 | 15.06 |
| 2025-12-04 | 14.87 |
| 2025-12-03 | 14.79 |
| 2025-12-02 | 14.55 |
| 2025-12-01 | 14.62 |
| 2025-11-28 | 14.89 |
| 2025-11-26 | 14.87 |
| 2025-11-25 | 14.88 |
| 2025-11-24 | 14.59 |
| 2025-11-21 | 14.48 |
| 2025-11-20 | 14.11 |
| 2025-11-19 | 14.39 |
| 2025-11-18 | 14.72 |
| 2025-11-17 | 14.51 |
| 2025-11-14 | 14.50 |
| 2025-11-13 | 14.92 |
| 2025-11-12 | 14.96 |
| 2025-11-11 | 14.76 |
| 2025-11-10 | 14.11 |
| 2025-11-07 | 14.13 |
| 2025-11-06 | 14.37 |
| 2025-11-05 | 14.24 |
| 2025-11-04 | 14.06 |
| 2025-11-03 | 14.26 |
| 2025-10-31 | 14.26 |
| 2025-10-30 | 14.05 |
| 2025-10-29 | 14.05 |
| 2025-10-28 | 14.17 |
| 2025-10-27 | 14.33 |
| 2025-10-24 | 14.32 |
| 2025-10-23 | 14.27 |
| 2025-10-22 | 14.30 |
| 2025-10-21 | 14.37 |
| 2025-10-20 | 14.28 |
| 2025-10-17 | 14.18 |
| 2025-10-16 | 14.02 |
| 2025-10-15 | 14.11 |
| 2025-10-14 | 14.18 |
| 2025-10-13 | 14.31 |
| 2025-10-10 | 14.33 |
| 2025-10-09 | 14.60 |
| 2025-10-08 | 14.85 |
| 2025-10-07 | 15.20 |
| 2025-10-06 | 15.29 |
| 2025-10-03 | 15.83 |